Market Overview

Mallinckrodt Rocked After Q4 Report

Andrew Left Predicts Eventual DOJ Prosecution Of Mallinckrodt For Selling HP Acthar Without Proven Efficacy
Imprimis Spins Off Eton Pharmaceuticals To Challenge Pricey Pipelines Of Mallinckrodt, Endo
Stocks Turn Mixed; China Names Falter While This Software Giant Breaks Out (Investor's Business Daily)

Mallinckrodt PLC (NYSE: MNK) shares are trading lower by $4.50 (8 percent) at $53.27 in Tuesday's session. Despite a Q4 EPS beat of a nickel along with slight revenue beat, the issue has found nothing but sellers off the opening bell.

After a lower open, it found resistance ahead of Monday's close ($57.67), only reaching $57.16 before sellers flooded the issue. The ensuing decline has taken the issue as low as $51.55, but rebounded back into the $53 handle.

The current low coincides with a trio of lows at the $51 area from mid-March.

Posted-In: Technicals Intraday Update Movers Trading Ideas


Related Articles (MNK)

View Comments and Join the Discussion!